Ionis Pharmaceuticals | IONS - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Alnylam Pharmaceuticals USD 898.54M 66.78M 2026-03
Arrowhead Research USD 215M 8.23M 2026-03
Astellas Pharma JPY 489.36B 52.69B 2026-03
BioCryst Pharmaceuticals USD -553.84M 700.01M 2026-03
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Celltrion KRW 140.68B 584.31B 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 359.47M 3.28M 2026-03
Halozyme Therapeutics USD 192.19M 18.88M 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.78B 242M 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Neurocrine Biosciences USD 599.9M 22.3M 2026-03
Novartis USD 9.29B 507M 2026-03
Omeros USD 59.16M 20.13M 2024-06
OPKO Health USD 186.77M 18.42M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pfizer USD 90.1B 77.19B 2026-03
Pharma Mar EUR 42.28M 4.59M 2026-03
PTC Therapeutics USD 226.66M 19.64M 2026-03
Qiagen NV USD 418.54M 23.25M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sarepta Therapeutics USD 372.37M 480.65M 2026-03
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tilray USD 237.52M 17.34M 2025-09
Ultragenyx Pharmaceutical USD 305M 16M 2026-03
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03